Compare BDX & AME Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BDX | AME |
|---|---|---|
| Founded | 1897 | 1930 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 48.2B | 57.0B |
| IPO Year | 1998 | 1998 |
| Metric | BDX | AME |
|---|---|---|
| Price | $199.42 | $238.53 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 20 |
| Target Price | $194.08 | ★ $282.06 |
| AVG Volume (30 Days) | ★ 1.4M | 1.2M |
| Earning Date | 11-05-2026 | 11-03-2026 |
| Dividend Yield | ★ 2.16% | 0.54% |
| EPS Growth | N/A | ★ 7.93 |
| EPS | 1.59 | ★ 3.51 |
| Revenue | ★ $21,840,000,000.00 | $7,401,116,000.00 |
| Revenue This Year | N/A | $14.17 |
| Revenue Next Year | $2.39 | $17.13 |
| P/E Ratio | $122.40 | ★ $71.35 |
| Revenue Growth | ★ 8.24 | 6.63 |
| 52 Week Low | $140.11 | $182.87 |
| 52 Week High | $213.08 | $261.16 |
| Indicator | BDX | AME |
|---|---|---|
| Relative Strength Index (RSI) | 71.52 | 38.88 |
| Support Level | $195.63 | $225.41 |
| Resistance Level | $211.18 | $241.89 |
| Average True Range (ATR) | 4.23 | 5.23 |
| MACD | 1.39 | -1.03 |
| Stochastic Oscillator | 98.71 | 19.54 |
Following the separation of the life science segment, Becton Dickinson operates in four business units. Medical essentials (35% of total sales) includes the legacy medical surgical unit, which sells catheters, syringes, and infection prevention products. Connected care (24%) core products include the Alaris infusion pump, Pyxis dispensing system, and pharmacy automation platforms. Biopharma systems (13%) produces prefillable syringes and autoinjectors. Interventional (29%) is composed of the surgery, peripheral vascular, and urology segments. More than 60% of revenue comes from the United States.
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns more than 40 autonomous industrial businesses operating across research, aerospace, energy, medical, and manufacturing. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets it operates in.